S-1 Impact 6/10 Ipo

$VRHID · Veri MedTech Holdings, Inc.

September 22, 2026 · AI-analyzed SEC filing

Veri Medtech Holdings filed Amendment No. 8 to its S-1 for a firm-commitment IPO of 3,750,000 shares at an assumed $4.00 per share, targeting approximately $15 million in gross proceeds. The company operates a medical marijuana card concierge platform through its Veriheal subsidiary, generating ~$11M in FY2025 revenue (down from ~$17M in FY2024) with a net loss of ~$2.32M. The offering is contingent on NASDAQ Capital Market listing approval; the company also plans to explore a dual listing on NASDAQ Texas.

Price data unavailable.

A declining-revenue cannabis-tech company with dual-class insider control is attempting a Nasdaq IPO at a discount to its OTC price — a high-risk capital raise in a federally hostile sector.

Veri Medtech operates a cannabis-adjacent healthcare platform connecting patients with physicians for medical marijuana cards. The sector faces persistent federal illegality headwinds, state-by-state regulatory fragmentation, and limited traditional banking access. Revenue contraction amid a growing

Revenue is declining sharply — FY2025 fell ~35% from FY2024, and H1 2026 is down ~27% YoY. The company operates in the federally illegal cannabis-adjacent space, creating banking, regulatory, and legal risks. Dual-class voting structure concentrates 80% voting control with two insiders via Series A,

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →